(Q54953894)

English

SK-MEL-19

cell line

SK-Mel-19
SKMEL-19
SK-MEL19
Sk Mel19
SKMEL19
AL-Mel

In more languages

Statements

1 reference

Cellosaurus release 49

14 July 2024

cancer cell line

1 reference

Cellosaurus release 49

14 July 2024

described by source

Absence of HeLa cell contamination in 169 cell lines derived from human tumors

1 reference

Cellosaurus release 49

14 July 2024

Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens

1 reference

Cellosaurus release 49

14 July 2024

Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells

1 reference

Cellosaurus release 49

14 July 2024

Induction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA

1 reference

Cellosaurus release 49

14 July 2024

Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection

1 reference

Cellosaurus release 49

14 July 2024

Loss of polymorphic restriction fragments in malignant melanoma: implications for tumor heterogeneity

1 reference

Cellosaurus release 49

14 July 2024

Human tumor lines for cancer research.

1 reference

Cellosaurus release 49

14 July 2024

Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies

1 reference

Cellosaurus release 49

14 July 2024

Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma

1 reference

Cellosaurus release 49

14 July 2024

Serological survey of normal humans for natural antibody to cell surface antigens of melanoma

1 reference

Cellosaurus release 49

14 July 2024

Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets

1 reference

Cellosaurus release 49

14 July 2024

Genomic profiling of malignant melanoma using tiling-resolution arrayCGH.

1 reference

Cellosaurus release 49

14 July 2024

Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring (V600E)BRAF

1 reference

Cellosaurus release 49

14 July 2024

Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence

1 reference

Cellosaurus release 49

14 July 2024

HLA-A, B, C and DR alloantigen expression on forty-six cultured human tumor cell lines

1 reference

Cellosaurus release 49

14 July 2024

Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progression

1 reference

Cellosaurus release 49

14 July 2024

Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets

1 reference

Cellosaurus release 49

14 July 2024

established from medical condition

1 reference

Cellosaurus release 49

14 July 2024

derived from organism type

1 reference

Cellosaurus release 49

14 July 2024

Identifiers

1 reference

Cellosaurus release 49

14 July 2024

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54953894&oldid=2204568276"